These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32646253)

  • 1. Prevention of bone loss and improvement of pain-related behavior in hind limb-unloaded mice by administration of teriparatide and bisphosphonate.
    Miyamura G; Wakabayashi H; Nagao N; Kato S; Nakagawa T; Naito Y; Sudo A
    Mod Rheumatol; 2021 May; 31(3):733-742. PubMed ID: 32646253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Block of Interleukin-6 Reduces a Bone Pain Marker but Not Bone Loss in Hindlimb-Unloaded Mice.
    Wakabayashi H; Miyamura G; Nagao N; Kato S; Naito Y; Sudo A
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of bisphosphonate on pain-related behavior and immunohistochemical analyses in hindlimb-unloaded mice.
    Nakagawa T; Wakabayashi H; Naito Y; Kato S; Miyamura G; Iino T; Sudo A
    J Orthop Sci; 2018 Nov; 23(6):1063-1069. PubMed ID: 30431005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 Inhibitor Suppresses Hyperalgesia Without Improvement in Osteoporosis in a Mouse Pain Model of Osteoporosis.
    Wakabayashi H; Kato S; Nagao N; Miyamura G; Naito Y; Sudo A
    Calcif Tissue Int; 2019 Jun; 104(6):658-666. PubMed ID: 30666355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teriparatide improves pain-related behavior and prevents bone loss in ovariectomized mice.
    Kato S; Wakabayashi H; Nakagawa T; Miyamura G; Naito Y; Iino T; Sudo A
    J Orthop Surg (Hong Kong); 2020; 28(1):2309499019893194. PubMed ID: 31833446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alendronate inhibits hyperalgesia and suppresses neuropeptide markers of pain in a mouse model of osteoporosis.
    Naito Y; Wakabayashi H; Kato S; Nakagawa T; Iino T; Sudo A
    J Orthop Sci; 2017 Jul; 22(4):771-777. PubMed ID: 28258808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA-4Ig Improves Hyperalgesia in a Mouse Model of Osteoporosis.
    Nagao N; Wakabayashi H; Miyamura G; Kato S; Naito Y; Sudo A
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate on cortical and trabecular bone of vertebra and proximal femur in postmenopausal women with fragility fracture: Sub-analysis by quantitative computed tomography from the TERABIT study.
    Takahashi R; Chiba K; Okazaki N; Era M; Yokota K; Yabe Y; Kondo C; Fukuda T; Fukushima K; Kono M; Michikoshi Y; Yamada S; Iida T; Mitsumizo K; Sato S; Doi M; Watanabe K; Ota S; Shiraishi K; Yonekura A; Osaki M
    Bone; 2024 Oct; 187():117189. PubMed ID: 38960296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-weekly parathyroid hormone combined with ongoing long-term alendronate treatment promotes osteoporotic fracture healing in ovariectomized rats.
    Zhang C; Zhu J; Jia J; Guan Z; Sun T; Zhang W; Yuan W; Wang H; Leng H; Song C
    J Orthop Res; 2021 Oct; 39(10):2103-2115. PubMed ID: 33325546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypersensitivity to cold stimulation associated with regional osteoporotic changes in tail-suspended mice.
    Ibe K; Iba K; Hanaka M; Kiyomoto K; Hayakawa H; Teramoto A; Emori M; Yamashita T
    J Bone Miner Metab; 2020 Jul; 38(4):469-480. PubMed ID: 32020290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of bisphosphonate with bone loss and pain-related behaviour in an adjuvant-induced osteoporosis model.
    Mayumi N; Wakabayashi H; Miyamura G; Sudo A
    Mod Rheumatol; 2024 Jul; 34(4):841-850. PubMed ID: 37616510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sequential osteoporosis treatments on trabecular bone in adult rats with low bone mass.
    Amugongo SK; Yao W; Jia J; Lay YA; Dai W; Jiang L; Walsh D; Li CS; Dave NK; Olivera D; Panganiban B; Ritchie RO; Lane NE
    Osteoporos Int; 2014 Jun; 25(6):1735-50. PubMed ID: 24722767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can the alendronate dosage be altered when combined with high-frequency loading in osteoporosis treatment?
    Correa CB; Camargos GV; Chatterjee M; Mesquita MF; Del Bel Cury AA; Naert I; Duyck J; Vandamme K
    Osteoporos Int; 2017 Apr; 28(4):1287-1293. PubMed ID: 27921147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of osteoporosis medications in a rat model of late-stage chronic kidney disease accompanied by secondary hyperparathyroidism and hyperphosphatemia.
    Ota M; Takahata M; Shimizu T; Kanehira Y; Kimura-Suda H; Kameda Y; Hamano H; Hiratsuka S; Sato D; Iwasaki N
    Osteoporos Int; 2017 Apr; 28(4):1481-1490. PubMed ID: 27933339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term daily teriparatide in patients with rheumatoid arthritis.
    Kaneko T; Okamura K; Yonemoto Y; Okura C; Suto T; Tachibana M; Tamura Y; Inoue M; Chikuda H
    Mod Rheumatol; 2018 May; 28(3):468-473. PubMed ID: 28805099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. μCT-based, in vivo dynamic bone histomorphometry allows 3D evaluation of the early responses of bone resorption and formation to PTH and alendronate combination therapy.
    de Bakker CM; Altman AR; Tseng WJ; Tribble MB; Li C; Chandra A; Qin L; Liu XS
    Bone; 2015 Apr; 73():198-207. PubMed ID: 25554598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of bisphosphonate wash-out prior to teriparatide therapy in clinical practice.
    Keel C; Kraenzlin ME; Kraenzlin CA; Müller B; Meier C
    J Bone Miner Metab; 2010; 28(1):68-76. PubMed ID: 19633810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.
    Ersan N; van Ruijven LJ; Bronckers AL; Olgaç V; Ilgüy D; Everts V
    Dentomaxillofac Radiol; 2014; 43(1):20130144. PubMed ID: 24170800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of teriparatide and alendronate on bone mineral density of osteoporotic rats].
    Li M; Jiao J; Meng XW; Xing XP; Xia WB; Zhou XY; Liu HC; Jiang Y; Wang O; Hu YY; Zhan ZW
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):335-8. PubMed ID: 15854512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of combination of alendronate and human parathyroid hormone(1-34) on bone strength are synergistic in the lumbar vertebra and additive in the femur of C57BL/6J mice.
    Johnston S; Andrews S; Shen V; Cosman F; Lindsay R; Dempster DW; Iida-Klein A
    Endocrinology; 2007 Sep; 148(9):4466-74. PubMed ID: 17569757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.